Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Switching to the Travoprost/Timolol Maleate Fixed Combination (DUOTRAV®) From Prior Mono or Two-Drug Therapy in Germany

NCT00519753 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT00519753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00519753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Switching to the Travoprost/Timolol Maleate Fixed Combination (DUOTRAV®) From Prior Mono or Two-Drug Therapy in Germany
Lead sponsor
Alcon Research
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2007
Completion date
December 31, 2008
Enrollment
522 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma